Pattern recognition by human γδ T cells and innate immunity.

人类 γδ T 细胞的模式识别和先天免疫。

基本信息

  • 批准号:
    12670299
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Innate immunity and acquired immunity play an essential role in human immune system, in which the former system recognize pathogen-associated molecular patterns and the latter non-self peptide antigens. The representative cells are macrophages and αβ T cells, respectively. Although human γδ T cells are considered to be involved in innate immunity since they recognize pyrophosphomonoesters and alkyl amines derived from pathogenic microbes, they are, on their other hand, classified as a member of acquired immunity based on their cell surface receptor generated as a result of gene rearrangement. In this study, immunological nature of human γδ T cells was elucidated by examining their recognition mechanism of nonpeptide antigens. Nitrogen-containing bisphosphonate was used in the present study. In the primary reaction, cell aggregation and interferon-γ Production were dependent on the existence of macrophage-lineage cells, indicating that antigen-presenting cells are involved in the recognition of nonpeptide antigens by γδ T cells. In addition, tumor cells were demonstrated to be able to present nonpeptide antigens to human γδ T cells in the secondary reaction. In order to elucidate the precise recognition mechanism of nonpeptide antigens by γδ T cell receptors, gene transfer system using a TCR-negative Jurkat cell line was employed, in which germline-encoded lysine residues in Jγ1.2 segment were shown to be involved in the interaction. This indicates that canonical sequence of γδ T cell receptors recognizes directly nonpeptide antigens, while γδ T cell receptors undergo gene rearrangement. Taken, together, human γδ T cells were confirmed to have two distinct characters, innate immunity and acquired immunity, on the basis of their mechanism for antigen recognition.
天然免疫和获得性免疫在人体免疫系统中起着重要的作用,前者识别病原体相关的分子模式,后者识别非自身多肽抗原。代表性细胞分别是巨噬细胞和αβ T细胞。虽然人γδ T细胞被认为参与先天免疫,因为它们识别来源于病原微生物的焦磷酸单酯和烷基胺,但另一方面,它们基于其作为基因重排的结果产生的细胞表面受体被分类为获得性免疫的成员。本研究通过检测人γδ T细胞对非肽类抗原的识别机制,阐明了人γδ T细胞的免疫学特性。在本研究中使用含氮双膦酸盐。在初级反应中,细胞聚集和γ-干扰素的产生依赖于巨噬细胞系细胞的存在,表明抗原呈递细胞参与γδ T细胞对非肽类抗原的识别。此外,肿瘤细胞被证明能够在二次反应中向人γδ T细胞呈递非肽抗原。为了阐明γδ T细胞受体对非肽类抗原的精确识别机制,采用TCR阴性的Jurkat细胞系进行基因转移,发现Jγ1.2片段中的种系编码赖氨酸残基参与了相互作用。这表明γδ T细胞受体的典型序列直接识别非肽类抗原,而γδ T细胞受体则经历基因重排。综上所述,基于其抗原识别机制,人γδ T细胞被证实具有两种不同的特性,即天然免疫和获得性免疫。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yu Kato, Yoshimasa Tanaka, Fumi Miyagawa, Seiji Yamashita, and Nagahiro Minato: "Targeting of tumor cells for human γδ T cells by nonpeptide antigens"The Journal of Immunology. 167. 5092-5098 (2001)
Yu Kato、Yoshimasa Tanaka、Fumi Miyakawa、Seiji Yamashita 和 Nagahiro Minato:“非肽抗原靶向人类 γδ T 细胞的肿瘤细胞”免疫学杂志 167. 5092-5098 (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Craig T. Morita, Hoi K. Lee, Hong Wang, Hongmin Li, Roy A. Mariuzza, and Yoshimasa Tanaka: "Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human γδ T cells"The Journal of Immunology. 167. 36-41 (2001)
Craig T. Morita、Hoi K. Lee、Hong Wang、Hongmin Li、Roy A. Mariuzza 和 Yoshimasa Tanaka:“非肽异戊二烯焦磷酸的结构特征决定其对人类 γδ T 细胞的抗原性”《免疫学杂志》167。 36。 -41 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hiroyuki Nishimura, Taku Okazaki, Yoshimasa Tanaka, Kazuki Nakatani, Masatake Hara, Akira, Matsumori, Shigetake Sasayama, Akira Mizoguchi, Hiroshi Hiai, Nagahiro Minato, and Tasuku Honjo: "Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice"
Hiroyuki Nishimura、Taku Okazaki、Yoshimasa Tanaka、Kazuki Nakatani、Masatake Hara、Akira、Matsumori、Shigetake Sasayama、Akira Mizoguchi、Hiroshi Hiai、Nagahiro Minato 和 Tasuku Honjo:“PD-1 受体缺陷型小鼠的自身免疫性扩张型心肌病”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hirohito Kobayashi, Yoshimasa Tanaka, Junji Yagi, Hiroshi Toma, Takehiko Uchiyama: "Gamma/delta T cells provide innate immunity against renal cell carcinoma"Cancer Immunology and Immunotherapy. 50. 115-124 (2001)
Hirohito Kobayashi、Yoshimasa Tanaka、Junji Yagi、Hiroshi Toma、Takehiko Uchiyama:“γ/δ T 细胞提供针对肾细胞癌的先天免疫”癌症免疫学和免疫治疗。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Seigo Korematsu, Yoshimasa Tanaka, Susumu Hosoi, Satoshi Koyanagi, Toyokazu Yokota, Bunzo Mikami, Nagahiro Minato: "C8/119S mutation of major mite allergen Derf-2 leads to degenerate secondary structure and molecular polymerization and induces potent and
Seigo Korematsu、Yoshimasa Tanaka、Susumu Hosoi、Satoshi Koyanagi、Toyokazu Yokota、Bunzo Mikami、Nagahiro Minato:“主要螨过敏原 Derf-2 的 C8/119S 突变导致二级结构和分子聚合的简并,并诱导有效和
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TANAKA Yoshimasa其他文献

TANAKA Yoshimasa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TANAKA Yoshimasa', 18)}}的其他基金

Development of cell preparations and high/low molecular-weight therapeutics that exhibit synergistic effects with PD-1 immune checkpoint antibodies
开发与PD-1免疫检查点抗体具有协同作用的细胞制剂和高/低分子量治疗剂
  • 批准号:
    16K08844
  • 财政年份:
    2016
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analyses of interaction between IL-18-induced helper NK cells and cytotoxic gamma delta T cells
IL-18 诱导的辅助 NK 细胞与细胞毒性 γ δ T 细胞之间相互作用的分析
  • 批准号:
    24590581
  • 财政年份:
    2012
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structural analysis of costimulatory molecules expressed on human γδ T cells
人γδ T细胞表达的共刺激分子的结构分析
  • 批准号:
    20590489
  • 财政年份:
    2008
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on generation mechanism of substorm by using high-resolution auroral data
利用高分辨率极光资料研究亚暴发生机制
  • 批准号:
    19740307
  • 财政年份:
    2007
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Identification of tumor antigens by the use of human γδ TCR tetramers
利用人γδ TCR四聚体鉴定肿瘤抗原
  • 批准号:
    18590470
  • 财政年份:
    2006
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of mechanism for nonpeptide antigen recognition by structural determination of mutated human γδ T cell receptor
通过突变人γδ T细胞受体的结构测定分析非肽抗原识别机制
  • 批准号:
    16590402
  • 财政年份:
    2004
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Enhacement of the effects of an angiogenesis inhibitor on murine tumors by hyperthermia
通过热疗增强血管生成抑制剂对小鼠肿瘤的作用
  • 批准号:
    07671033
  • 财政年份:
    1995
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Measurement of extracellular pH decrease cased by hyperthermiaand drugs on tumor cells.
测量热疗和药物对肿瘤细胞造成的细胞外 pH 值降低。
  • 批准号:
    04670682
  • 财政年份:
    1992
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Roles of DNA topoisomerase II in the development of the cellular slime molds.
DNA 拓扑异构酶 II 在细胞粘菌发育中的作用。
  • 批准号:
    02640518
  • 财政年份:
    1990
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Measurement of pH in tumor tissue by 31P-MRS and microelectrode after glucose injection.
注射葡萄糖后用 31P-MRS 和微电极测量肿瘤组织的 pH 值。
  • 批准号:
    01570597
  • 财政年份:
    1989
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

外泌体ORM1作为肿瘤免疫微环境中T细胞耗竭(T Cell Exhaustion)生物标志物及其功能研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

A T cell STAT3/BATF-axis regulates intestinal γδ T cell homeostasis and disease
T 细胞 STAT3/BATF 轴调节肠道 γT 细胞稳态和疾病
  • 批准号:
    10752335
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Molecular and genomic control of innate γδ T cell development
先天γδ T 细胞发育的分子和基因组控制
  • 批准号:
    10226997
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
Molecular and physical mechanisms that underpin the αβ versus γδ T cell fate decision
支持 αβ 与 γδ T 细胞命运决定的分子和物理机制
  • 批准号:
    10462551
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
Molecular and physical mechanisms that underpin the αβ versus γδ T cell fate decision
支持 αβ 与 γδ T 细胞命运决定的分子和物理机制
  • 批准号:
    10226999
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
Molecular and physical mechanisms that underpin the αβ versus γδ T cell fate decision
支持 αβ 与 γδ T 细胞命运决定的分子和物理机制
  • 批准号:
    10685633
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
Molecular and genomic control of innate γδ T cell development
先天γδ T 细胞发育的分子和基因组控制
  • 批准号:
    10462548
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
Molecular and genomic control of innate γδ T cell development
先天γδ T 细胞发育的分子和基因组控制
  • 批准号:
    10685628
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
Analysis of mechanism for nonpeptide antigen recognition by structural determination of mutated human γδ T cell receptor
通过突变人γδ T细胞受体的结构测定分析非肽抗原识别机制
  • 批准号:
    16590402
  • 财政年份:
    2004
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
γδ T cell versus NK cell function in intestinal immunity
γδ T 细胞与 NK 细胞在肠道免疫中的功能
  • 批准号:
    453662420
  • 财政年份:
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Units
Strategies to enhance cytotoxicity of tumor-infiltrating γδ T-cell subsets against autologous tumor cells
增强肿瘤浸润 γδ T 细胞亚群对自体肿瘤细胞的细胞毒性的策略
  • 批准号:
    412071939
  • 财政年份:
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Units
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了